How far have we progressed in the field of CLL research? Patient advocate Carol Preston, on location at the 2015 American Society of Hematology (ASH) meeting, visited with leading CLL expert Dr. Richard Furman to hear his perspective on news from the conference. Listen as Dr. Furman gives a rundown of last years novel agents and todays best possibility for deep remission.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo